ROS levels were higher in CD8+ T cells of LGLL patients compared to healthy controls, which is consistent with previous studies showing increased level of ROS in hematological malignancies [50, 51]. The gene discussed is CD8A; the disease is T-cell large granular lymphocyte leukemia.